ProTrials’ senior management continues to monitor the global COVID-19 pandemic with a focus to protect study patients and our employees, while ensuring  business continuity with our sponsor partners. We stay abreast of latest guidance from the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and other national health organizations.

We remain focused on providing support to our sponsors and study sites who are on the front line of healthcare and patient safety.  Here are the actions we take to mitigate risk while maintaining business continuity:

• Following governmental travel restrictions and advice for all regions where we operate to ensure safety of our staff and colleagues.
• Providing flexible work arrangements to ensure consistent project coverage. We remotely monitor all systems and have a core team in our headquarters to ensure integrity of systems.
• Activating business continuity plans to ensure delivery of our project commitments. Study teams work with clients and vendor partners to ensure deliverables are met, and proactively work together to develop solutions as needed (e.g., remote monitoring per SOP).
• Cooperating with study sites to ensure access to proper clinical care on-site or remotely, including creation of contingency plans for availability of study related medication and supplies.
• Working with our sponsor partners to implement technologies that support virtual patient assessments and site management activities.

Our decisions have been and will continue to be guided by our commitment to deliver the best service and outcome to our customers while also maintaining concern for the well-being of the patients, the site staff, and our employees.  We continue to assess the evolving impact of the pandemic, and we recognize that your project may have unique considerations.

The clinical research community is uniquely positioned to help develop therapies as well as a vaccine.  ProTrials has supported vaccine and infectious disease trials since 1996 and nearly 60% of our clinical staff have related trial experience.  We have managed vaccine trials focused on COVID-19, flu, HIV, meningitis, oncology, hepatitis B, smallpox, anthrax, among others, and are ready to support new trials in this area.

Please reach out to us if we can be of assistance, we are here to help.

Jodi Andrews & Inger Arum

Founders and Co-CEOs